Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIV
Mathieu Chalouni(Harvard University), Sara Lodi(Boston University), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Giota Touloumi(National Institute Of Hygiene And Epidemiology), Johannes Nemeth(University of Zurich), Anders Boyd, Bernard Surial(University of Bern), Marina B. Klein(Royal Victoria Regional Health Centre), Christopher T. Rentsch(University of London), Juan Berenguer(Instituto de Salud Carlos III), Inmaculada Jarrín(Instituto de Salud Carlos III), Sophia M. Rein(Harvard University), Daniela K van Santen(Burnet Institute), Jessie Torgersen(Center for Clinical Research (United States)), Miguel A. Hernán(Harvard University), A. Papadopoulos(National and Kapodistrian University of Athens), Van der Valk(Netherlands Center for Occupational Diseases), Benjamin P Linas(Boston University), Antonella D’arminio Monforte, Jim Young(McGill University Health Centre), M John Gill(University of Calgary), Roger W. Logan(Harvard University), José M. Miro(Hospital Clínic de Barcelona), Linda Wittkop(Université de Bordeaux), Robert Zangerle(Innsbruck Medical University), Rachel Epstein(Boston University)
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Observational Studies Analyzed Like Randomized Experiments
|Epidemiology|2008|814